BioCentury | Jul 20, 2018
Company News
Cas3 antimicrobial company acquires Epibiome tech
...Biosciences Inc. (Research Triangle Park, N.C.) acquired a phage discovery platform from fellow antibacterial company EpiBiome Inc....
...specific pathogenic species while sparing human cells and the microbiome (see "Cutting Through Resistance" ). EpiBiome’s...
...EpiBiome Inc., South San Francisco, Calif. Locus Biosciences Inc., Research Triangle Park, N.C. Business: Infectious Elizabeth S. Eaton EpiBiome Inc. Locus...
...specific pathogenic species while sparing human cells and the microbiome (see "Cutting Through Resistance" ). EpiBiome’s...
...EpiBiome Inc., South San Francisco, Calif. Locus Biosciences Inc., Research Triangle Park, N.C. Business: Infectious Elizabeth S. Eaton EpiBiome Inc. Locus...